Synektik Stock - Ksiazek Holding sells 16.13% stake via ABB

Synektik stock comes into focus after Ksiazek Holding placed its entire 16.13% stake in the Polish medical-technology group through an accelerated bookbuild at PLN 300 per share, crystallizing a sizable gain on a long-term investment.

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 15:00 CET. Details in the imprint.

Synektik (PLSYNEK00016) is in the news after shareholder Ksiazek Holding sold its entire 16.13% stake through an accelerated bookbuild. The block of 1.38 million shares was placed at PLN 300 per share, according to a Reuters-distributed notice on the transaction.

Details of the ABB transaction

According to a Reuters-based market notice, Synektik announced that an accelerated bookbuild placed 1.38 million existing shares, equal to 16.13% of its share capital, at PLN 300 per share. The shares were sold by Ksiazek Holding, a long-standing shareholder.

A separate filing distributed via the Polish corporate news system confirms the completion of the bookbuild process and notes that the shares are admitted to trading on the Warsaw Stock Exchange. The sale was executed as a secondary placement, with no new capital raised for the company itself.

Wednesday lens on operations and strategy

While the ABB reshuffles the shareholder base, Synektik continues to position itself as a leading supplier of da Vinci surgical robots and imaging solutions in Poland. Management recently highlighted significant growth potential in robotic surgery volumes through 2030 in general surgery.

In an interview cited by ISBnews, the company noted that robot-assisted procedures could reach 6-7% of all general surgery cases in Poland by 2030, up from a low single-digit share today. This outlook underpins its strategy of expanding installed da Vinci capacity and related service revenues.

How the company makes money

Synektik generates revenue primarily by distributing and servicing Intuitive Surgical’s da Vinci robotic surgery systems in Poland, alongside advanced diagnostic imaging solutions. It also offers radiopharmaceuticals and related services, giving the group exposure to both capital equipment and recurring healthcare revenue streams.

Where the stock trades today

The shares of Synektik (PLSYNEK00016) trade on the Warsaw Stock Exchange at PLN 319.00 as of 06/17/2026, 15:00 CET.

Key facts on Synektik stock

• Company: Synektik S.A.
• ISIN: PLSYNEK00016
• WKN: 0VTZ
• Ticker: SNT
• Venue: Warsaw Stock Exchange
• Price (as of 06/17/2026, 15:00 CET): 319.00 PLN
• Market cap: 2,728,000,000 PLN (as of 06/17/2026)
• Sector / Industry: Health Care / Medical Technology
• Index membership: WIG30
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.